Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease
in Western countries, and typically affects the elderly. BP is immunologically characterized …

Bullous pemphigoid (BP) is the most common autoimmune bullous disorder which is
characterized by autoantibodies against hemidesmosomal proteins of the skin and mucous …

Background Bullous pemphigoid (BP) is the most common autoimmune subepidermal
blistering disease of the skin and mucous membranes. This disease typically affects the …

Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of
the skin and mucous membranes. This disease typically affects the elderly and presents with …

Cutaneous lupus erythematosus (CLE) is a rare inflammatory autoimmune disease with
heterogeneous clinical manifestations. To date, no therapeutic agents have been licensed …

In the first part of the review, topical agents and first-line systemic treatment options for
cutaneous lupus erythematosus were discussed whereas in the second part, recent …

Superpotent topical corticosteroids (CS) have been demonstrated to improve bullous
pemphigoid (BP) patients' survival. We assessed whether a mild regimen using lower doses …

The overall objective of the guideline is to provide up-to-date, evidence-based
recommendations for the management of bullous pemphigoid (BP). The document aims to …

Interventions for bullous pemphigoid - Kirtschig, G - 2010 | Cochrane Library Skip to Content
Cookies Our site uses cookies to improve your experience. You can find out more about our …

Bullous pemphigoid (BP) constitutes the most frequent autoimmune subepidermal blistering
disease. It is associated with autoantibodies directed against the BP antigens 180 (BP180 …